Total Payments
$286,176
2024 Payments
$49,879
Companies
15
Transactions
345
Medicare Patients
564
Medicare Billing
$206,626
Payment Breakdown by Category
Other$208,680 (72.9%)
Consulting$32,745 (11.4%)
Travel$22,385 (7.8%)
Research$13,430 (4.7%)
Food & Beverage$8,936 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,880 | 69 | 58.7% |
| Honoraria | $40,800 | 30 | 14.3% |
| Consulting Fee | $32,745 | 17 | 11.4% |
| Travel and Lodging | $22,385 | 94 | 7.8% |
| Unspecified | $13,430 | 24 | 4.7% |
| Food and Beverage | $8,936 | 111 | 3.1% |
Payments by Type
General
$272,747
321 transactions
Research
$13,430
24 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $135,329 | 142 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $66,833 | 102 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $55,552 | 50 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,430 | 24 | $0 (2024) |
| AstraZeneca UK Limited | $11,680 | 4 | $0 (2023) |
| BTG International, Inc. | $1,400 | 1 | $0 (2024) |
| Advanced Circulatory Systems Inc. | $400.00 | 1 | $0 (2018) |
| Bard Access Systems, Inc. | $300.00 | 1 | $0 (2020) |
| BARD PERIPHERAL VASCULAR, INC. | $300.00 | 1 | $0 (2019) |
| Prytime Medical Devices, Inc. | $283.74 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,879 | 61 | AstraZeneca Pharmaceuticals LP ($35,836) |
| 2023 | $61,058 | 74 | AstraZeneca Pharmaceuticals LP ($47,915) |
| 2022 | $55,750 | 54 | AstraZeneca Pharmaceuticals LP ($51,579) |
| 2021 | $51,380 | 46 | Alexion Pharmaceuticals, Inc. ($51,380) |
| 2020 | $16,447 | 27 | PORTOLA PHARMACEUTICALS, LLC ($15,950) |
| 2019 | $31,255 | 46 | PORTOLA PHARMACEUTICALS, INC. ($30,939) |
| 2018 | $20,356 | 35 | PORTOLA PHARMACEUTICALS, INC. ($19,944) |
| 2017 | $50.94 | 2 | Zimmer Biomet Holdings, Inc. ($50.94) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| 10/15/2024 | BTG International, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Rare Disease | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $77.11 | General |
| Category: Rare Disease | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: Rare Disease | ||||||
| 09/08/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $50.94 | General |
| Category: Rare Disease | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Rare Disease | ||||||
| 06/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Rare Disease | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Rare Disease | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Rare Disease | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Rare Disease | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $23.85 | General |
| Category: Rare Disease | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: Rare Disease | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $24.43 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $84.12 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $29.48 | General |
| Category: Rare Disease | ||||||
| 05/18/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $56.00 | General |
| Category: Rare Disease | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $575.60 | General |
| Category: Rare Disease | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $575.60 | General |
| Category: Rare Disease | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $194.07 | General |
| Category: Rare Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF TAK-330 FOR REVERSAL OF DIRECT ORAL FACTOR XA INHIBITOR-INDUCED ANTICOAGULATION | Takeda Pharmaceuticals U.S.A., Inc. | $12,286 | 12 |
| A Study of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation | Takeda Pharmaceuticals U.S.A., Inc. | $1,144 | 12 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 117 | 179 | $238,214 | $35,783 |
| 2022 | 8 | 168 | 293 | $301,911 | $45,775 |
| 2021 | 6 | 138 | 258 | $275,405 | $50,390 |
| 2020 | 4 | 141 | 380 | $291,384 | $74,678 |
Total Patients
564
Total Services
1,110
Medicare Billing
$206,626
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 22558 | Fusion of lower spine bone through abdomen with partial removal of disc | Facility | 2023 | 18 | 18 | $121,320 | $14,698 | 12.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 68 | $80,512 | $11,906 | 14.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 35 | $10,465 | $3,359 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $13,637 | $2,282 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,195 | $1,896 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 25 | $5,085 | $1,642 | 32.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 114 | $134,976 | $19,964 | 14.8% |
| 22558 | Fusion of lower spine bone through abdomen with partial removal of disc | Facility | 2022 | 16 | 16 | $107,840 | $13,195 | 12.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 52 | $7,370 | $3,072 | 41.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 35 | $6,860 | $2,987 | 43.5% |
| 22585 | Fusion of spine bones through front of body with partial removal of disc, each additional disc | Facility | 2022 | 11 | 12 | $29,892 | $2,121 | 7.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $7,635 | $1,829 | 24.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $3,417 | $1,509 | 44.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 34 | $3,921 | $1,097 | 28.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 57 | 161 | $138,845 | $30,038 | 21.6% |
| 22558 | Fusion of spine bones with removal of disc at lower spinal column, anterior approach | Facility | 2021 | 17 | 17 | $114,580 | $13,909 | 12.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $10,180 | $2,544 | 25.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,710 | $1,638 | 34.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 23 | 39 | $4,598 | $1,231 | 26.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $2,492 | $1,029 | 41.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 98 | 321 | $207,434 | $61,143 | 29.5% |
| 22558 | Fusion of spine bones with removal of disc at lower spinal column, anterior approach | Facility | 2020 | 11 | 11 | $74,140 | $9,337 | 12.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 33 | $6,953 | $2,868 | 41.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 15 | 15 | $2,857 | $1,331 | 46.6% |
About Dr. Niels Martin, MD
Dr. Niels Martin, MD is a Surgery healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013073477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niels Martin, MD has received a total of $286,176 in payments from pharmaceutical and medical device companies, with $49,879 received in 2024. These payments were reported across 345 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($167,880).
As a Medicare-enrolled provider, Martin has provided services to 564 Medicare beneficiaries, totaling 1,110 services with total Medicare billing of $206,626. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgical Critical Care, Trauma Surgery
- Location Philadelphia, PA
- Active Since 12/29/2006
- Last Updated 12/24/2025
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1013073477
Products in Payments
- ANDEXXA (Biological) $183,275
- Andexxa (Drug) $51,380
- ANDEXXA (Drug) $16,269
- BEVYXXA (Drug) $3,674
- ER-REBOA PLUS (Device) $283.74
- ABTHERA (Device) $196.73
- FLOSEAL (Biological) $143.75
- QuikClot (Device) $66.08
- Rib Fix Blu (Device) $63.43
- RibFix Blu (Device) $15.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Philadelphia
Wilson Szeto, Md, MD
Surgery — Payments: $300,133
Surgery $300,133
Pavan Atluri, Md, MD
Surgery — Payments: $158,685
Surgery $158,685
David Wernsing, Md, MD
Surgery — Payments: $125,762
Surgery $125,762
Scott Kozin, M.d, M.D
Surgery — Payments: $96,292
Surgery $96,292
Paris Butler, Md, MD
Surgery — Payments: $91,657
Surgery $91,657
Mark Kaplan, Md, MD
Surgery — Payments: $91,433
Surgery $91,433